José R Cortés1, Teresa Palomero. 1. aInstitute for Cancer Genetics, Columbia University bDepartment of Pathology and Cell Biology, Columbia University Medical Center, New York, USA.
Abstract
PURPOSE OF REVIEW: Once an obscure disease, recent studies have transformed our understanding of angioimmunoblastic T-cell lymphoma (AITL). In this review, we summarize new major advances in the genetics and biology of AITL. RECENT FINDINGS: Genome wide sequencing studies have dissected the repertoire of the genetic alterations driving AITL uncovering a highly recurrent Gly17Val somatic mutation in the small GTPase RHOA and major role for mutations in epigenetic regulators, such as TET2, DNMT3A and IDH2, and signaling factors (e.g., FYN and CD28). These findings support a multistep model of follicular T helper cell transformation in AITL and pinpoint novel candidates for the development of targeted therapies in this disease. SUMMARY: AITL originates from follicular T helper cells and is characterized by the presence of RHOA G17V mutation together with genetic alterations in TET2, DNMT3A, and IDH2. Research efforts now focus on the elucidation of the specific roles and interplay of these genetic alterations in the pathogenesis of AITL.
PURPOSE OF REVIEW: Once an obscure disease, recent studies have transformed our understanding of angioimmunoblastic T-cell lymphoma (AITL). In this review, we summarize new major advances in the genetics and biology of AITL. RECENT FINDINGS: Genome wide sequencing studies have dissected the repertoire of the genetic alterations driving AITL uncovering a highly recurrent Gly17Val somatic mutation in the small GTPase RHOA and major role for mutations in epigenetic regulators, such as TET2, DNMT3A and IDH2, and signaling factors (e.g., FYN and CD28). These findings support a multistep model of follicular T helper cell transformation in AITL and pinpoint novel candidates for the development of targeted therapies in this disease. SUMMARY: AITL originates from follicular T helper cells and is characterized by the presence of RHOAG17V mutation together with genetic alterations in TET2, DNMT3A, and IDH2. Research efforts now focus on the elucidation of the specific roles and interplay of these genetic alterations in the pathogenesis of AITL.
Authors: Andrew M Platt; Vivienne B Gibson; Agapitos Patakas; Robert A Benson; Steven G Nadler; James M Brewer; Iain B McInnes; Paul Garside Journal: J Immunol Date: 2010-07-02 Impact factor: 5.422
Authors: Timothy J Ley; Li Ding; Matthew J Walter; Michael D McLellan; Tamara Lamprecht; David E Larson; Cyriac Kandoth; Jacqueline E Payton; Jack Baty; John Welch; Christopher C Harris; Cheryl F Lichti; R Reid Townsend; Robert S Fulton; David J Dooling; Daniel C Koboldt; Heather Schmidt; Qunyuan Zhang; John R Osborne; Ling Lin; Michelle O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Sean D McGrath; Lucinda A Fulton; Vincent J Magrini; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Joshua J Conyers; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd Wylie; Jason Walker; Joelle Kalicki; Mark A Watson; Sharon Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Peter Westervelt; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Richard K Wilson Journal: N Engl J Med Date: 2010-11-10 Impact factor: 91.245
Authors: Marta Cuadros; Sandeep S Dave; Elaine S Jaffe; Emiliano Honrado; Roger Milne; Javier Alves; Jose Rodríguez; Magdalena Zajac; Javier Benitez; Louis M Staudt; Beatriz Martinez-Delgado Journal: J Clin Oncol Date: 2007-06-18 Impact factor: 44.544
Authors: David Hong; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Morvarid Mohseni; Deborah Lawson; Corinne Reimer; David C Blakey; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod Journal: Sci Transl Med Date: 2015-11-18 Impact factor: 17.956
Authors: Hongxiang Zeng; Hailan He; Lei Guo; Jia Li; Minjung Lee; Wei Han; Anna G Guzman; Shengbing Zang; Yubin Zhou; Xiaotian Zhang; Margaret A Goodell; Katherine Y King; Deqiang Sun; Yun Huang Journal: Cancer Lett Date: 2019-09-26 Impact factor: 8.679
Authors: Mariano G Cardenas; Erin Oswald; Wenbo Yu; Fengtian Xue; Alexander D MacKerell; Ari M Melnick Journal: Clin Cancer Res Date: 2016-11-23 Impact factor: 12.531
Authors: Thomas A Rasmussen; James McMahon; J Judy Chang; Jori Symons; Michael Roche; Ashanti Dantanarayana; Afam Okoye; Bonnie Hiener; Sarah Palmer; Wen Shi Lee; Stephen J Kent; Carrie Van Der Weyden; H Miles Prince; Paul U Cameron; Sharon R Lewin Journal: AIDS Date: 2017-08-24 Impact factor: 4.177
Authors: Joanna Mangana; Emmanuella Guenova; Katrin Kerl; Mirjana Urosevic-Maiwald; Valerie C Amann; Cornelia Bayard; Reinhard Dummer; Lars E French Journal: Case Rep Dermatol Date: 2017-03-21